What is Paraclipse?
Paraclipse operates as a premier provider of non-toxic, ultraviolet-based insect control systems, catering to a diverse clientele across the foodservice, hospitality, and agricultural industries. The company distinguishes itself through its patented Capture Cartridge technology, which offers a sanitary and environmentally conscious alternative to traditional chemical-based pest control methods. By prioritizing both aesthetic integration and high-performance efficacy, Paraclipse has established a strong market presence for its flagship products, including the Outdoor Fly Patrol and Mosquito Eliminator. Their commitment to safety and sanitation aligns with increasing regulatory demands for sustainable facility management solutions, positioning the company as a critical partner for businesses seeking to maintain high hygiene standards without compromising environmental integrity.
How much funding has Paraclipse raised?
Paraclipse has raised a total of $121K across 1 funding round:
Debt
$121K
Debt (2021): $121K with participation from PPP
Key Investors in Paraclipse
PPP
Public-Private Partnership
What's next for Paraclipse?
With the infusion of this capital, Paraclipse is poised to transition into a phase of aggressive market expansion and product diversification. The strategic focus will likely center on scaling the distribution of its ultraviolet systems to meet the growing demand for non-toxic pest management in commercial environments. Furthermore, the company is expected to invest in research and development to refine its Capture Cartridge technology, potentially exploring new applications in industrial-scale agriculture. As the firm navigates this late-stage growth trajectory, the emphasis will remain on solidifying its competitive moat through innovation and operational excellence, ensuring that its environmentally friendly solutions remain the industry standard for sanitation-focused pest control.
See full Paraclipse company page
